High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives

References

• Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999;49:8–31.
   PubMed Web of Science ®Google Scholar
• Catalona WJ, Smith DS, Ratliff TL, Basler JW. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 1993;270:948–54.
   PubMed Web of Science ®Google Scholar
• Albertsen PC, Hanley JA, Barrows GH, Penson DF, Kowalczyk PD, Sanders MM, et al. Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst 2005;97:1248–53.
   PubMedGoogle Scholar
• Screening for prostate cancer: draft recommendation statement. Rockville, MD: US Preventive Services Task Force, October 7. 2011. http://www.uspreventiveservicestaskforce.org/draftrec3.htm.
   Google Scholar
• Prostate-specific antigen best practice statement: 2009 update. Linthicum, MD: American Urological Association. 2009. http:/www.auanet.org/content/media/psa09.pdf.
   Google Scholar
• Wolf AMD, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ, et al. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin 2010;60:70–98.
   PubMed Web of Science ®Google Scholar
• Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter. N Engl J Med 2004;350:2239–46; Erratum: N Engl J Med 2004;351:1470.
   PubMed Web of Science ®Google Scholar
• Department of Health and Human Services. ASPE issue brief – overview of the uninsured in the United States: a summary of the 2011 current population survey. September 13. 2011. http://aspe.hhs.gov/health/reports/2011/CPSHealthIns2011/ib.pdf.
   Google Scholar
• Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 2008;148:435.
   PubMed Web of Science ®Google Scholar
• Ahmed HU, Freeman A, Kirkham A, Sahu M, Scott R, Allen C, et al. Focal therapy for localized prostate cancer: a phase I/II trial. J Urol 2011;185:1246–54.
   PubMedGoogle Scholar
• Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 2010;28:1117–23.
   PubMed Web of Science ®Google Scholar
• Klotz L, Zhang L, Lam A, Nam ER, Mamedov A, Loblaw A. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010;28:126.
   PubMed Web of Science ®Google Scholar
• Tseng KS, Landis P, Epstein JI, Trock BJ, Carter HB. Risk stratification of men choosing surveillance for low risk prostate cancer. J Urol 2010;183:1779–85.
   Google Scholar
• Sciarra A, Barentsz J, Bjartell A, Eastham J, Hricak H, Panebianco V, et al. Advances in magnetic resonance imaging: how they are changing the management of prostate cancer [review]. Eur Urol 2011;59:962–77.
   PubMed Web of Science ®Google Scholar
• Kennedy JE, Ter Haar GR, Cranston D. High intensity focused ultrasound: surgery of the future? Br J Radiol 2003;76:590–9.
   PubMed Web of Science ®Google Scholar
• Kennedy JE. High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer 2005;5:321–7.
   PubMed Web of Science ®Google Scholar
• Thüroff S, Chaussy C, Vallancien G, Wieland W, Kiel HJ, Le Duc A, et al. High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J Endourol 2003;17:673–7.
   PubMed Web of Science ®Google Scholar
• Poissonnier L, Chapelon JY, Rouviere O. Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol 2007;51:381–7.
   PubMed Web of Science ®Google Scholar
• Mallick S, Dufour A, Fouques Y. High intensity focused ultrasound for the treatment of localized prostate cancer: are its efficacy and morbidity dogmatic [abstract]. J Urol 2006. http://www.abstracts-2view.com/aua_archive/view.php?nu=200691912
   Google Scholar
• Chaussy C, Thüroff S. The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr Urol Rep 2003;4:248–52.
   PubMedGoogle Scholar
• Blana A, Rogenhofer S, Ganzer R, Lunz JC, Schostak M, Wieland WF, et al. Eight years' experience with high-intensity focused ultrasonography for treatment of localized prostate cancer. Urology 2008;72:1329–33.
   PubMed Web of Science ®Google Scholar
• Crouzet S, Rebillard X, Chevallier D, Rischmann P, Pasticier G, Garcia G, et al. Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients. Eur Urol 2010;58:559–66.
   PubMed Web of Science ®Google Scholar
• Agarwal PK, Sadetsky N, Konety BR, Resnik MI, Carroll PR. Cancer of the prostate strategic urological research endeavor (CaPSURE). Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer 2008;112:307–14.
   PubMed Web of Science ®Google Scholar
• Chaussy CG, Thüroff SF. HIFU treatment of locally advanced prostate cancer. J Endourol 2010;24:PS12–12.
   Google Scholar
• http://www.uroweb.org/guidelines/online-guidelines/PROSTATE CANCER.
   Google Scholar
• http://www.auanet.org/content/clinical-practice-guidelines/clinical-guidelines/main reports/proscan07/content.
   Google Scholar
• Murota-Kawano A, Nakano M, Hongo S, Shoji S, Nagata Y, Uchida T. Salvage high-intensity focused ultrasound for biopsy-confirmed local recurrence of prostate cancer after radical prostatectomy. BJU Int 2010;105:1642–5.
   PubMed Web of Science ®Google Scholar
• Asimakopoulos AD, Miano R, Virgili G, Vespasiani G, Finazzi Agrò E. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study. Urol Oncol 2011;Feb1 Epub ahead of print.
   Google Scholar
• Uchida T, Shoji S, Nakano M, Hongo S, Nitta M, Usui Y, et al. High-intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after external beam radiation, brachytherapy or proton therapy. BJU Int 2011;107:378–82.
   PubMed Web of Science ®Google Scholar
• Murat FJ, Poissonnier L, Rabilloud M, Belot A, Bouvier R, Rouviere O, et al. Mid-term results demonstrate salvage high intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer. Eur Urol 2009;55:640–9.
   PubMed Web of Science ®Google Scholar
• Gelet A, Chapelon JY, Poissonnier L, Bouvier R, Rouvière O, Curiel L, et al. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology 2004;63:625–9.
   PubMed Web of Science ®Google Scholar
• Chaussy CG, Thüroff SF. Robotic high-intensity focused ultrasound for prostate cancer: what have we learned in 15 years of clinical use? Curr Urol Rep 2011;12:180–7.
   Google Scholar
• Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 2003;169:517–23.
   PubMed Web of Science ®Google Scholar
• Chun FK, Graefen M, Zacharias M, Haese A, Steuber T, Schlomm T, et al. Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer. World J Urol 2006;24:273–80.
   PubMed Web of Science ®Google Scholar
• Tasso M. Prostate cancer: transrectal high-intensity focused ultrasound for the treatment of local recurrence after radical prostatectomy or radiotherapy. Urologia 2009;76:73–6.
   Google Scholar
• Chaussy C, Thuroff S, Nanieva R. Hormone resistant prostate cancer treated by robotic high intensive ultrasound. J Urol 2010;183(Suppl):e262.
   Google Scholar
• Uchida T, Ohkusa H, Yamashita H, Shoji S, Nagata Y, Hyodo T, et al. Five years experience of transrectal high-intensity focused ultrasound using the Sonoblate device in the treatment of localized prostate cancer. Int J Urol 2006;13:228–33.
   PubMed Web of Science ®Google Scholar
• Ahmed HU, Moore C, Emberton M. Minimally-invasive technologies in uro-oncology: the role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer. Surg Oncol 2009;18:219–32.
   PubMed Web of Science ®Google Scholar
• Blana A, Murat FJ, Walter B. First analysis of the long-term results with transrectal HIFU in patients with localized prostate cancer. Eur Urol 2008;53:1194–201.
   PubMed Web of Science ®Google Scholar
• Blana A, Hierl J, Rogenhofer S, Lunz JC, Wieland WF, Walter B, et al. Factors predicting for formation of bladder outlet obstruction after high-intensity focused ultrasound in treatment of localized prostate cancer. Urology 2008;71:863–7.
   Google Scholar
• Shoji S, Nakano M, Nagata Y, Usui Y, Terachi T, Uchida T. Quality of life following high-intensity focused ultrasound for the treatment of localized prostate cancer: a prospective study. Int J Urol 2010;17:715–19.
   PubMedGoogle Scholar
• Marberger M, Carroll PR, Zelefsky MJ, Coleman JA, Hrika H, Scardino PT, et al. New treatments for localized prostate cancer. Urology 2008;72:S36–43.
   Google Scholar
• Thüroff S, Knauer K, Chaussy C. Ten years high intensity focused ultrasound (HIFU) as local treatment of prostate cancer: profile of side effects. Eur Urol Suppl 2006;5:132.
   Google Scholar
• Bataineh O, Jenne J, Huber P. Clinical and future applications of high intensity focused ultrasound in cancer. Cancer Treat Rev 2012;38:346–53.
   Google Scholar
• Guzmán HR, Mcnamara AJ, Nguyen DX, Prausnitz MR. Bioeffects caused by changes in acoustic cavitation bubble density and cell concentration: a unified explanation based on cell-to-bubble ratio and blast radius. Ultrasound Med Biol 2003;29:1211–22.
   PubMed Web of Science ®Google Scholar
• Bradley WG Jr. MR-guided focused ultrasound: a potentially disruptive technology. J Am Coll Radiol 2009;6:510–13.
   PubMedGoogle Scholar
• Madersbacher S, Pedevilla M, Vingers L, Susani M, Marberger M. Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res 1995;55:3346–51.
   PubMed Web of Science ®Google Scholar
• Muto S, Yoshii T, Saito K, Kamiyama Y, Ide H, Horie S. Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer. Jpn J Clin Oncol 2008;38:192–9.
   PubMed Web of Science ®Google Scholar
• Blana A, Brown SC, Chaussy C. High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure. Int BJU 2009;104:1058–62.
   PubMed Web of Science ®Google Scholar
• Gelet A, Chapelon JY, Bouvier R, Rouvière O, Lyonnet D, Dubernard JM. Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing the outcome. Eur Urol 2001;40:124–9.
   PubMed Web of Science ®Google Scholar
• Ganzer R, Rogenhofer S, Walter B, Lunz JC, Schostak M, Wieland WF, et al. PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localized prostate cancer. Eur Urol 2008;53:547–53.
   PubMed Web of Science ®Google Scholar
• Mearini L, D'Urso L, Collura D, Zucchi A, Costantini E, Formiconi A, et al. Transrectal high-intensity focused ultrasound (HIFU) using the Sonablate® 500 for the treatment of prostate cancer; the Perugia–Torino experience [abstract]. Eur Urol Suppl 2008;7:120.
   Google Scholar
• Mearini L, D'Urso L, Collura D, Zucchi A, Costantini E, Formiconi A, et al. Visually directed transrectal high intensity focused ultrasound for the treatment of prostate cancer: a preliminary report on the Italian experience. J Urol 2009;181:105–11.
   PubMed Web of Science ®Google Scholar
• Murat FJ, Chapelon JY, Poissonnier L. Salvage HIFU for radiorecurrent prostate cancer: factors influencing the outcome [abstract]. Eur Urol Suppl 2006;5:133.
   Google Scholar
• Poissonnier L, Gelet A, Chapelon Y. Local recurrence of prostate cancer after external beam radiation: early experience of salvage therapy using high intensity focused ultrasound [abstract]. Eur Urol Suppl 2005;7:79.
   Google Scholar
• Mallick S, Dufour A, Fouques Y, Bensadoun H. Salvage therapy using high-intensity focused ultrasound for local recurrence of prostate cancer after radiation therapy [abstract]. Eur Urol Suppl 2006;5:132.
   Google Scholar
• Murat FJ, Poissonnier L, Rouvière O. Salvage high intensity focused ultrasound (HIFU) treatment for recurrent prostate cancer after radiation therapy: high efficacy in patients with good initial prognosis [abstract]. http://www.sciencedirect.com/science?_ob=RedirectURL&_method=externObjLink&_locator=url&_issn=09366555&_origin=article&_zone=art_page&_plusSign=%2B&_targetURL=http%253A%252F%252Fwww.abstracts2view.com%252Faua_archive%252Fview.php%25253Fnu%25253D200794031.
   Google Scholar
• Murat FJ, Poissonnier L, Pricaz E. Prognostic factors for salvage HIFU success after external beam radiation failure (EBRT) failure [abstract]. Eur Urol Suppl 2008;7:119.
   Google Scholar
• Murat FJ, Poissonnier L, Rouvière O. High efficacy of salvage HIFU treatment for radiorecurrent prostate cancer in patient with good initial prognosis [abstract]. J Urol 2007;6:200.
   Google Scholar
• Thüroff S, Chaussy C, Vallancien G, Wieland W, Kiel HJ, Le Duc A, et al. High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J Endourol 2003;17:673–7.
   PubMed Web of Science ®Google Scholar
• Chaussy C, Thüroff S. The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr Urol Rep 2003;4:248–52.
   PubMedGoogle Scholar
• Uchida T, Baba S, Irie A, Soh S, Masumori N, Tsukamoto T, et al. Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer: a multicenter study. Hinyokika Kiyo 2005;51:651–8.
   PubMedGoogle Scholar
• Gelet A, Chapelon J, Bouvier R, Rouvière O, Lyonnet D, Dubernard J. Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer. J Endourol 2000;14:519–28.
   PubMed Web of Science ®Google Scholar